Wilmer Cutler Pickering Hale and Dorr LLP advised Verve Therapeutics on the deal. Verve Therapeutics, a biotech company pioneering gene editing medicines to treat cardiovascular disease,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
